Telix to Showcase ZIRCON Phase III Kidney Cancer Imaging Dat

/PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations from the Company's investigational prostate...

Related Keywords

United Kingdom , United States , Australia , Switzerland , Japan , Canada , Chicago , Illinois , Melbourne , Victoria , Belgium , Australian , Nat Lenzo , Colin Hayward , Andrewm Scott , Kyahn Williamson , David Schuster , Harshad Kulkarni , Merck Kga , Md Olivia Newton John Cancer Research Institute , Society Of Nuclear Medicine , Md Emory University , Trobe University , European Union , Drug Administration , Corporate Communications , Health Canada , Australian Securities Exchange , Linkedin , Merck Kgaa , Australian Therapeutic Goods Administration , Telix Pharmaceuticals , Prnewswire Telix Pharmaceuticals Limited , Pharmaceuticals Limited , Nuclear Medicine , Molecular Imaging , Jeremie Calais , Chief Medical Officer , Clinical Studies , Urologic Malignancies , Preclinical Oncology Models , Olivia Newton John Cancer Research Institute , Clinical Therapy , Emory University , Telix Pharmaceuticals Limited ,